The Latest Breaking News from JNJ

Let’s take a look at Barchart’s Bear Call Spread Screener for December 19th:

The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D efforts. Thus, investors could consider quality healthcare innovator stocks Johnson & Johnson (JNJ), Merck & Co (MRK), and Bristol-Myers Squibb (BMY) as portfolio additions for potential gains. Continue reading.

For investors seeking a balanced approach, healthcare ETFs offer a combination of stability and growth potential. Therefore, it might be wise to consider Fidelity MSCI Health Care Index ETF (FHLC), iShares U.S. Healthcare ETF (IYH), and Vanguard Health Care Index Fund ETF Shares (VHT) for a balanced approach. Keep reading….

Johnson & Johnson has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

Amid ongoing uncertainties surrounding the economy and global power dynamics, market volatility continues to dominate. In such times, investing in fundamentally sound blue-chip stocks, Johnson & Johnson (JNJ), American Express (AXP), and AT&T (T), could offer investors a stable foundation, serving as a buffer against market fluctuations and uncertainty. Read…

Dividend Aristocrats offer stability, reliable income, and risk mitigation, with consistent dividend growth helping to combat uncertain times. Hence, it could be wise to add top Dividend Aristocrats like Johnson & Johnson (JNJ), PepsiCo (PEP), and Kimberly-Clark (KMB) to your portfolio. Read on.

During market volatility and economic downturns, investors often turn to stocks offering stable dividends and growth opportunities. Thus, quality dividend stocks Johnson & Johnson (JNJ), Lowe's Companies (LOW), and Target Corporation (TGT) could be ideal portfolio additions for long-term wealth. Continue reading.

Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for portfolio protection. Thus, quality defensive stocks Johnson & Johnson (JNJ), Pfizer (PFE), and Genie Energy (GNE) could be ideal portfolio additions as market volatility rises. Continue reading.

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

Dividend stocks are a top choice for long-term investors, with dependable payout and steady performance. Therefore, it could be wise to keep track of top dividend stocks, such as Johnson & Johnson (JNJ), Northwest Natural Holding Co. (NWN), and Universal Corp (UVV). Read more….